中国感染控制杂志2016，Vol.15Issue(2)：108-110,3.DOI:10.3969/j.issn.1671-9638.2016.02.009
某院重症医学科2010-2013年鲍曼不动杆菌耐药性监测
Monitoring of antimicrobial resistance of Acinetobacter baumannii in the intensive care unit of a hospital from 2010 to 2013
摘要
Abstract
Objective To analyze the isolation rates and antimicrobial resistance of Acinetobacter baumannii (AB) from intensive care unit (ICU)between 2010 and 2013,and provide evidence for clinical anti-infective therapy. Methods The isolation and antimicrobial resistance of AB from ICU between 2010 and 2013 were analyzed retro-spectively.Results A total of 1 413 pathogenic strains were isolated,556(39.35%)of which were AB,isolation rates in each year were 39.45%,41 .35%,29.44%,and 40.53% respectively.AB were mainly isolated from lower respiratory tract (75.72%).Antimicrobial susceptibility testing results showed that AB had low resistance rates to cefoperazone/sulbactam(5.85%)and amikacin (17.45%);detection rates of multidrug-resistant and extensively drug-resistant AB increased from 9.63% and 3.70% to 42.50% and 31 .88%,respectively (both P < 0.001 ). Conclusion AB is the common pathogen in ICU,antimicrobial resistance is serious,isolation of multidrug-resistant and extensively drug-resistant AB increased year by year;intensifying the monitoring of drug resistance is helpful for the treat-ment and prevention of AB infection.关键词
重症医学科/鲍曼不动杆菌/抗药性,微生物/合理用药/耐药性Key words
intensive care unit/Acinetobacter baumannii/drug resistance,microbial/rational drug use/drug re-sistance分类
医药卫生引用本文复制引用
王金荣,高攀,崔朝勃,杜红利,刘淑红,高秀玲,郭淑芬..某院重症医学科2010-2013年鲍曼不动杆菌耐药性监测[J].中国感染控制杂志,2016,15(2):108-110,3.基金项目
河北省卫生厅基金 （）
